Humanin Isoforms in Cardiac Muscle and Blood Plasma and Major Complications After Cardiac Operation
NCT ID: NCT03431844
Last Updated: 2020-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
106 participants
OBSERVATIONAL
2018-01-01
2019-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis of the study is that previously described elements are related to each other.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perioperative Myocardial Ischemia: Troponin Monitoring,Cost-effectiveness, Insights Into Pathophysiology
NCT03438448
High-sensitivity Troponin in Cardiac Surgery
NCT01913873
N-terminal Pro B-type Natriuretic Peptide (Nt-proBNP) Versus Exercise Test for Evaluation of Acute Chest Pain
NCT00493844
Hydration Status Assessment Through Body Composition Monitoring in Patients With Acute Myocardial Infarction
NCT02655341
Observational Study of the Remodelling Process Following Myocardial Infarct
NCT00338156
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Specimen collection:
* Tissue sample is taken during the operation from the right atrial appendage of the heart and the sample is frozen at -80 C.
* Blood samples are taken just before the operation, one hour after aortic cross-clamp removal and the next morning after the operation. Samples are processed and blood plasma is frozen at -80 C.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ischemic heart disease in medical history
* Planned on-pump coronary artery bypass graft (CABG) operation
* Signed informed consent by patient
Exclusion Criteria
* Planned isolate valve or aortic operation
* Patient is in another study with an intervention
* Absence of signed informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tartu University Hospital
OTHER
North Estonia Medical Centre
OTHER
University of Tartu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Henery Kroon
Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joel Starkopf, MD, PhD
Role: STUDY_DIRECTOR
Tartu University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
North Estonia Medical Centre
Tallinn, Harju, Estonia
Tartu University Hospital
Tartu, Tartu, Estonia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HN1160
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.